Manali Rupji

12PUBLICATIONS
46CO-AUTHORS
Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsCounselling psychologyHaematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (12)

|Jul 26, 2026
Impact of Adjuvant Chemotherapy on Overall Survival in Early-Onset Stage II-III Mucinous Adenocarcinoma of The Colon: A Propensity-Based Analysis.

|Feb 26, 2025
Impact of Systemic and Radiation Therapy on Survival of Primary Central Nervous System Lymphoma.

James Robert Janopaul-Naylor, Jimmy S Patel, Manali Rupji

|Apr 08, 2024
Targeting TRIP13 in favorable histology Wilms tumor with nuclear export inhibitors synergizes with doxorubicin.

Karuna Mittal, Garrett W Cooper, Benjamin P Lee

|Nov 29, 2022
Engagement and outcomes of cancer patients referred to a tobacco cessation program at a National Cancer Institute-designated cancer center.

Sarah A Westergaard, Manali Rupji, Lauren E Franklin

|Mar 04, 2022
Obesity-induced galectin-9 is a therapeutic target in B-cell acute lymphoblastic leukemia.

Miyoung Lee, Jamie A G Hamilton, Ganesh R Talekar

|Jan 30, 2021
The level of oncogenic Ras determines the malignant transformation of Lkb1 mutant tissue in vivo.

Briana Rackley, Chang-Soo Seong, Evan Kiely

Pageof 2

Frequent Collaborators

1 joint publications

Jeanne Kowalski

1 joint publications

Lindsey Lowder

1 joint publications

Jennifer L Rabe

1 joint publications

Jill E Slansky